Odontogenic Keratocyst (OKC)

The odontogenic keratocyst (OKC) is a unique and aggressive cystic lesion of the jaw with distinct histological features and a high recurrence rate. Below is a comprehensive overview of its characteristics, treatment options, and prognosis.

Characteristics of Odontogenic Keratocyst

1. Definition and Origin:

   • The term "odontogenic keratocyst" was first introduced by Philipsen in 1956. It is believed to originate from remnants of the dental lamina or basal cells of the oral epithelium.

2. Biological Behavior:

   • OKCs exhibit aggressive behavior and have a recurrence rate of 13% to 60%. They are considered to have a neoplastic nature rather than a purely developmental origin.

3. Histological Features:

   • The cyst lining is typically 6 to 10 cells thick, with a palisaded basal cell layer and a surface of corrugated parakeratin.
   • The epithelium may produce orthokeratin (10%), parakeratin (83%), or both (7%).
   • No rete ridges are present, and mitotic activity is frequent, contributing to the cyst's growth pattern.

4. Types:

   • Orthokeratinized OKC: Less aggressive, lower recurrence rate, often associated with dentigerous cysts.
   • Parakeratinized OKC: More aggressive with a higher recurrence rate.

5. Clinical Features:

   • Age: Peak incidence occurs in individuals aged 20 to 30 years.
   • Gender: Predilection for males (approximately 1:5 male to female ratio).
   • Location: More commonly found in the mandible, particularly in the ramus and third molar area. In the maxilla, the third molar area is also a common site.
   • Symptoms: Patients may be asymptomatic, but symptoms can include pain, soft-tissue swelling, drainage, and paresthesia of the lip or teeth.

6. Radiographic Features:

   • Typically appears as a unilocular lesion with a well-defined peripheral rim, although multilocular varieties (20%) can occur.
   • Scalloping of the borders is often present, and it may be associated with the crown of a retained tooth (40%).

Treatment Options for Odontogenic Keratocyst

1. Surgical Excision:

   • Enucleation: Complete removal of the cyst along with the surrounding tissue.
   • Curettage: Scraping of the cyst lining after enucleation to remove any residual cystic tissue.

2. Chemical Cauterization:

   • Carnoy’s Solution: Application of Carnoy’s solution (6 ml absolute alcohol, 3 ml chloroform, and 1 ml acetic acid) after enucleation and curettage can help reduce recurrence rates. It penetrates the bone and can assist in freeing the cyst from the bone wall.

3. Marsupialization:

   • This technique involves creating a window in the cyst to allow for drainage and reduction in size, which can be beneficial in larger cysts or in cases where complete excision is not feasible.

4. Primary Closure:

   • After enucleation and curettage, the site may be closed primarily or packed open to allow for healing.

5. Follow-Up:

   • Regular follow-up is essential due to the high recurrence rate. Patients should be monitored for signs of recurrence, especially in the first few years post-treatment.

Prognosis

• The prognosis for OKC is variable, with a significant recurrence rate attributed to the aggressive nature of the lesion and the potential for residual cystic tissue.
• Recurrence is not necessarily related to the size of the cyst or the presence of satellite cysts but is influenced by the nature of the lesion itself and the presence of dental lamina remnants.
• Multilocular lesions tend to have a higher recurrence rate compared to unilocular ones.
• Surgical technique does not significantly influence the likelihood of relapse.

Associated Conditions

• Multiple OKCs can be seen in syndromes such as:
  • Nevoid Basal Cell Carcinoma Syndrome (Gorlin-Goltz Syndrome)
  • Marfan Syndrome
  • Ehlers-Danlos Syndrome
  • Noonan Syndrome

Airway Management in Medical Emergencies: Tracheostomy and Cricothyrotomy

1. Establishing a Patent Airway

• Immediate Goal: The primary objective in any emergency involving airway obstruction is to ensure that the patient has a clear and patent airway to facilitate breathing.
• Procedures Available: Various techniques exist to achieve this, ranging from nonsurgical methods to surgical interventions.

2. Surgical Interventions

A. Tracheostomy

• A tracheostomy is a surgical procedure that involves creating an opening in the trachea (windpipe) through the neck to establish an airway.
• Indications:
  • Prolonged mechanical ventilation.
  • Severe upper airway obstruction (e.g., due to tumors, trauma, or swelling).
  • Need for airway protection in patients with impaired consciousness or neuromuscular disorders.
• Procedure:
  • An incision is made in the skin over the trachea, A tracheostomy incision is made between the second and third tracheal rings, which is below the larynx. The incision is usually 2–3 cm long and can be vertical or horizontaland the trachea is then opened to insert a tracheostomy tube.
  • This procedure requires considerable knowledge of anatomy and technical skill to perform safely and effectively.

B. Cricothyrotomy

• Definition: A cricothyrotomy is a surgical procedure that involves making an incision through the skin over the cricothyroid membrane (located between the thyroid and cricoid cartilages) to establish an airway.
• Indications:
  • Emergency situations where rapid access to the airway is required, especially when intubation is not possible.
  • Situations where facial or neck trauma makes traditional intubation difficult.
• Procedure:
  • A vertical incision is made over the cricothyroid membrane, and a tube is inserted directly into the trachea.
  • This procedure is typically quicker and easier to perform than a tracheostomy, making it suitable for emergency situations.

3. Nonsurgical Techniques for Airway Management

A. Abdominal Thrust (Heimlich Maneuver)

•  The Heimlich maneuver is a lifesaving technique used to relieve choking caused by a foreign body obstructing the airway.
• Technique:
  • The rescuer stands behind the patient and wraps their arms around the patient's waist.
  • A fist is placed just above the navel, and quick, inward and upward thrusts are applied to create pressure in the abdomen, which can help expel the foreign object.
• Indications: This technique is the first-line approach for conscious patients experiencing airway obstruction.

B. Back Blows and Chest Thrusts

• Back Blows:
  • The rescuer delivers firm blows to the back between the shoulder blades using the heel of the hand. This can help dislodge an object obstructing the airway.
• Chest Thrusts:
  • For patients who are obese or pregnant, chest thrusts may be more effective. The rescuer stands behind the patient and performs thrusts to the chest, similar to the Heimlich maneuver.

Local Anesthetic (LA) Toxicity and Dosing Guidelines

Local anesthetics (LAs) are widely used in various medical and dental procedures to provide pain relief. However, it is essential to understand their effects on the cardiovascular system, potential toxicity, and appropriate dosing guidelines to ensure patient safety.

Sensitivity of the Cardiovascular System

• The cardiovascular system is generally less sensitive to local anesthetics compared to the central nervous system (CNS). However, toxicity can still lead to significant cardiovascular effects.

Effects of Local Anesthetic Toxicity

1. Mild Toxicity (5-10 μg/ml):

   • Myocardial Depression: Decreased contractility of the heart muscle.
   • Decreased Cardiac Output: Reduced efficiency of the heart in pumping blood.
   • Peripheral Vasodilation: Widening of blood vessels, leading to decreased blood pressure.

2. Severe Toxicity (Above 10 μg/ml):

   • Intensification of Effects: The cardiovascular effects become more pronounced, including:
     • Massive Vasodilation: Significant drop in blood pressure.
     • Reduction in Myocardial Contractility: Further decrease in the heart's ability to contract effectively.
     • Severe Bradycardia: Abnormally slow heart rate.
     • Possible Cardiac Arrest: Life-threatening condition requiring immediate intervention.

Dosing Guidelines for Local Anesthetics

1. With Vasoconstrictor:

   • Maximum Recommended Dose:
     • 7 mg/kg body weight
     • Should not exceed 500 mg total.

2. Without Vasoconstrictor:

   • Maximum Recommended Dose:
     • 4 mg/kg body weight
     • Should not exceed 300 mg total.

Special Considerations for Dosing

• The maximum calculated drug dose should always be decreased in certain populations to minimize the risk of toxicity:
  • Medically Compromised Patients: Individuals with underlying health conditions that may affect drug metabolism or cardiovascular function.
  • Debilitated Patients: Those who are physically weakened or have reduced physiological reserve.
  • Elderly Persons: Older adults may have altered pharmacokinetics and increased sensitivity to medications.

Nasogastric Tube (Ryles Tube)

A nasogastric tube (NG tube), commonly referred to as a Ryles tube, is a medical device used for various purposes, primarily involving the stomach. It is a long, hollow tube made of polyvinyl chloride (PVC) with one blunt end and multiple openings along its length. The tube is designed to be inserted through the nostril, down the esophagus, and into the stomach.

Description and Insertion

• Structure: The NG tube has a blunt end that is inserted into the nostril, and it features multiple openings to allow for the passage of fluids and air. The open end of the tube is used for feeding or drainage.

• Insertion Technique:

  1. The tube is gently passed through one of the nostrils and advanced through the nasopharynx and into the esophagus.
  2. Care is taken to ensure that the tube follows the natural curvature of the nasal passages and esophagus.
  3. Once the tube is in place, its position must be confirmed before any feeds or medications are administered.

• Position Confirmation:

  • To check the position of the tube, air is pushed into the tube using a syringe.
  • The presence of air in the stomach is confirmed by auscultation with a stethoscope, listening for the characteristic "whoosh" sound of air entering the stomach.
  • Only after confirming that the tube is correctly positioned in the stomach should feeding or medication administration begin.

• Securing the Tube: The tube is fixed to the nose using sticking plaster or adhesive tape to prevent displacement.

Uses of Nasogastric Tube

1. Nutritional Support:

   • Enteral Feeding: The primary use of a nasogastric tube is to provide nutritional support to patients who are unable to take oral feeds due to various reasons, such as:
     • Neurological conditions (e.g., stroke, coma)
     • Surgical procedures affecting the gastrointestinal tract
     • Severe dysphagia (difficulty swallowing)

2. Gastric Lavage:

   • Postoperative Care: NG tubes can be used for gastric lavage to flush out blood, fluids, or other contents from the stomach after surgery. This is particularly important in cases where there is a risk of aspiration or when the stomach needs to be emptied.
   • Poisoning: In cases of poisoning or overdose, gastric lavage may be performed using an NG tube to remove toxic substances from the stomach. This procedure should be done promptly and under medical supervision.

3. Decompression:

   • Relieving Distension: The NG tube can also be used to decompress the stomach in cases of bowel obstruction or ileus, allowing for the removal of excess gas and fluid.

4. Medication Administration:

   • The tube can be used to administer medications directly into the stomach for patients who cannot take oral medications.

Considerations and Complications

• Patient Comfort: Insertion of the NG tube can be uncomfortable for patients, and proper technique should be used to minimize discomfort.

• Complications: Potential complications include:

  • Nasal and esophageal irritation or injury
  • Misplacement of the tube into the lungs, leading to aspiration
  • Sinusitis or nasal ulceration with prolonged use
  • Gastrointestinal complications, such as gastric erosion or ulceration

• Trismus case extraction: Use Vazirani – Akinosi closed mouth mandibular nerve block
• Pregnancy – safe anesthetics: Category B (Lignocaine, Prilocaine, Etidocaine)
• Common allergen in LA: Methylparaben (preservative in multi – dose vials)
• MI patient on aspirin: Do not stop aspirin for extraction
• Steroid patient (RA): Double steroid dose before surgery
• AV malformation: Pre – op embolization, extract after 48 – 72 hrs
• Safe adrenaline dose (cardiac patient): 0.04 mg
• Max dose of 2% lignocaine with 1:200,000 adrenaline (60 kg adult): 21 mL
• Local anesthetic mechanism: Blocks inactivated Na⁺ channels
• Unionized form (RNH⁺): Enters nerve terminal
• Ionized form (RN⁺H₃): Active inside cell
• Metabolism of amide LA: Liver via P – 450 enzymes
• LA half – lives: Lidocaine – 90 min, Bupivacaine – 200 min, Articaine – 20 – 40 min
• Least toxic LA: Chloroprocaine
• Antioxidant for vasoconstrictor in LA: Sodium bisulfite/metabisulfite
• Noradrenaline not used with lignocaine: Causes intense vasoconstriction